Cancer vaccines aim at eliciting tumor‐specific responses for the immune system to identify
and eradicate malignant tumor cells while sparing the normal tissues. Furthermore, cancer …

The advent of immunotherapy has revolutionized the treating modalities of cancer. Cancer
vaccine, aiming to harness the host immune system to induce a tumor‐specific killing effect …

In recent years, personalized cancer vaccines have gained increasing attention as emerging
immunotherapies with the capability to overcome interindividual differences and show great …

Nanomaterial-based delivery vehicles such as lipid-based, polymer-based, inorganics-
based, and bio-inspired vehicles often carry distinct and attractive advantages in the …

Recent breakthroughs in cancer immunotherapy offer new paradigm-shifting therapeutic
options for combating cancer. Personalized therapeutic anti-cancer vaccines training T cells …

Immunotherapy is a promising treatment modality for cancer as it can promote specific and
durable anti-cancer responses. However, limitations to current approaches remain …

Tumor vaccination is a promising approach for tumor immunotherapy because it presents
high specificity and few side effects. However, tumor vaccines that contain only a single …

The development of therapeutic cancer vaccines as a means to generate immune reactivity
against tumors has been explored since the early discovery of tumor-specific antigens by …

Cancer immunotherapies including cancer vaccines, immune checkpoint blockade or
chimeric antigen receptor T cells have been exploited as the attractive treatment modalities …

The recent success of immunotherapies has highlighted the power of leveraging the
immune system in the fight against cancer. In order for most immune‐based therapies to …